![John Bondo Hansen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
John Bondo Hansen
Fondatore presso Conrig Pharma ApS
Posizioni attive di John Bondo Hansen
Società | Posizione | Inizio | Fine |
---|---|---|---|
Pcovery ApS
![]() Pcovery ApS Pharmaceuticals: MajorHealth Technology Pcovery ApS develops drugs for treatment of invasive fungal infections. It discovers a new class of fungal therapy by targeting an essential and highly conserved component of the fungal cell membrane. The company was founded by Morten J. Buch-Pedersen, Michael Broberg Palmgren, Claus Olesen and Poul Nissen in 2009 and is headquartered in Copenhagen, Denmark. | Corporate Officer/Principal | - | - |
Direttore operativo | 26/08/2011 | - | |
Conrig Pharma ApS
![]() Conrig Pharma ApS Pharmaceuticals: MajorHealth Technology Conrig Pharma ApS provides drug for oral treatment of atopical disease. Its new drug (CRG-010) is use for topical treatment of itch/pruritus associated with atopical dermatitis. The company was founded by John Bondo Hansen and Mikael Sondergaard Thomsen on December 20, 2010 and is headquartered in Copenhagen, Denmark. | Direttore/Membro del Consiglio | 20/12/2010 | - |
Amministratore Delegato | 20/12/2010 | - | |
Fondatore | 20/12/2010 | - |
Storia della carriera di John Bondo Hansen
Precedenti posizioni note di John Bondo Hansen
Società | Posizione | Inizio | Fine |
---|---|---|---|
Sound Biotechnology, Inc. | Direttore Tecnico/Scientifico/R&S | 01/01/2010 | 01/01/2010 |
Fondatore | 01/01/2008 | 01/01/2010 | |
NOVO NORDISK A/S | Corporate Officer/Principal | 01/01/2002 | - |
Contera Pharma ApS
![]() Contera Pharma ApS Pharmaceuticals: MajorHealth Technology Contera Pharma ApS is a holding company that identifies and develops treatments for patients suffering from movement disorders. It develops drug candidates based on a combination of repositioning, combinations, and reformulations. The firm's lead project JM-010 is for treatment of dyskinesia associated with Parkinson's disease. It develops an approach of using a combination therapy to tackle clinically relevant synergistic pathways to obtain therapeutic effects which will generate efficacious therapeutic entities based on robust pre-clinical and clinical evidence. The company was founded by Mikael Søndergaard Thomsen and John Bondo Hansen in 2010 and is headquartered in Copenhagen, Denmark. | Amministratore Delegato | - | - |
Fondatore | - | - | |
Konticon Consulting, Inc. | Amministratore Delegato | 01/01/2008 | - |
Fondatore | 01/01/2008 | - | |
Aurigene Discovery Technologies Ltd.
![]() Aurigene Discovery Technologies Ltd. BiotechnologyHealth Technology Aurigene Discovery Technologies Ltd. operates as biotechnology company. It offers research services such as integrated research and stand-alone research. The company is headquartered in Bangalore, India. | Direttore/Membro del Consiglio | 26/08/2011 | - |
Formazione di John Bondo Hansen
University of Copenhagen | Doctorate Degree |
Statistiche
Distribuzione geografica
Danimarca | 6 |
Stati Uniti | 3 |
India | 2 |
Posizioni
Founder | 4 |
Chief Executive Officer | 3 |
Corporate Officer/Principal | 2 |
Settori
Health Technology | 6 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
NOVO NORDISK A/S | Health Technology |
Aziende private | 6 |
---|---|
Pcovery ApS
![]() Pcovery ApS Pharmaceuticals: MajorHealth Technology Pcovery ApS develops drugs for treatment of invasive fungal infections. It discovers a new class of fungal therapy by targeting an essential and highly conserved component of the fungal cell membrane. The company was founded by Morten J. Buch-Pedersen, Michael Broberg Palmgren, Claus Olesen and Poul Nissen in 2009 and is headquartered in Copenhagen, Denmark. | Health Technology |
Aurigene Discovery Technologies Ltd.
![]() Aurigene Discovery Technologies Ltd. BiotechnologyHealth Technology Aurigene Discovery Technologies Ltd. operates as biotechnology company. It offers research services such as integrated research and stand-alone research. The company is headquartered in Bangalore, India. | Health Technology |
Sound Biotechnology, Inc. | |
Konticon Consulting, Inc. | |
Conrig Pharma ApS
![]() Conrig Pharma ApS Pharmaceuticals: MajorHealth Technology Conrig Pharma ApS provides drug for oral treatment of atopical disease. Its new drug (CRG-010) is use for topical treatment of itch/pruritus associated with atopical dermatitis. The company was founded by John Bondo Hansen and Mikael Sondergaard Thomsen on December 20, 2010 and is headquartered in Copenhagen, Denmark. | Health Technology |
Contera Pharma ApS
![]() Contera Pharma ApS Pharmaceuticals: MajorHealth Technology Contera Pharma ApS is a holding company that identifies and develops treatments for patients suffering from movement disorders. It develops drug candidates based on a combination of repositioning, combinations, and reformulations. The firm's lead project JM-010 is for treatment of dyskinesia associated with Parkinson's disease. It develops an approach of using a combination therapy to tackle clinically relevant synergistic pathways to obtain therapeutic effects which will generate efficacious therapeutic entities based on robust pre-clinical and clinical evidence. The company was founded by Mikael Søndergaard Thomsen and John Bondo Hansen in 2010 and is headquartered in Copenhagen, Denmark. | Health Technology |
- Borsa valori
- Insiders
- John Bondo Hansen
- Esperienza